תראקאפ 131

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

SODIUM IODIDE (131 I)

MAH:

ELDAN ELECTRONIC INSTRUMENTS CO LTD, ISRAEL

ATC_code:

V09FX03

pharmaceutical_form:

קפסולה קשיחה

composition:

SODIUM IODIDE (131 I) 37 - 5550 MBQ

administration_route:

פומי

prescription_type:

מרשם נדרש

manufactured_by:

GE HEALTHCARE BUCHLER GmbH & Co. KG

therapeutic_group:

SODIUM IODIDE (131I)

therapeutic_area:

SODIUM IODIDE (131I)

therapeutic_indication:

Theracap 131 is a radioiodine thyroid therapy indicated for: 1. Treatment of Graves' disease, as well as focal or disseminated autonomies of the thyroid.2.Treatment of papillary and follicular thyroid carcinomas including metastases. - Whole-body-scintigraphy for monitoring papillary or follicular thyroid carcinoma. Sodium iodide 131 therapy is often combined with surgical intervention and with antithyroid medications.

authorization_date:

2015-09-30